Ara-290
Powder Peptides
An EPO-derived peptide studied for neuropathic pain, small fiber neuropathy, and tissue protection.
nerve painneuropathyinflammation
Learn More← All peptides
Powder Peptides
Serelaxin
heart healthinflammationrecovery
What the research explores
Serelaxin is recombinant human Relaxin-2, developed for the treatment of acute heart failure. It is studied for its cardiovascular benefits, including reducing mortality in heart failure patients.
In the literature, Serelaxin appears most often in work focused on heart health, inflammation and recovery. Studies in this area tend to look at mechanisms and observed effects in laboratory and preclinical settings rather than outcomes in people, so the picture is best read as a map of where researchers have been curious — not as evidence of any benefit.
Serelaxin is catalogued here under powder peptides. Coverage of this compound varies in quality and depth, and much of it remains early-stage. Reading the underlying research directly is the only way to judge how strong any particular finding is.
Commonly searched for
Tap a topic to see which peptides are most studied for it.
Related peptides
CJC-1295 (DAC)
Powder Peptides
A long-acting growth-hormone-releasing hormone analog studied for sustained GH and IGF-1 elevation.
growth hormoneanti-agingrecoverymuscle
Learn MoreCJC-1295 (DAC) + Ipamorelin
Powder Peptides
A synergistic GH stack studied for muscle recovery, sleep quality, and body composition.
growth hormonemusclerecoverysleep
Learn MoreResearch use only. This page summarizes areas of published study and is not medical advice. No dosing, protocol, or usage guidance is provided.